Clinics and pathology

Disease
Myoepithelioma tumours of soft tissue cover a wide range of tumours of various behaviour. While most are of intermediate aggressivity, some metastasize. There is no sex ratio predominance. Mean age at diagnosis is 38 years; with a range of 3-83 years. Of a hundred of cases reviewed by Hornick and Fletcher (2003) , 60% were benign and classified as myoepitheliomas or mixed tumors, and 40% were classified as myoepithelial carcinomas or malignant mixed tumours. Amongst cases with benign or low-grade cytology, with a mean follow-up of 3 years, 20% recurred locally and none metastasized. Amongst cytologically malignant cases, with a mean follow-up of 4 years, 40% recurred locally, 1/3 metastasized, and 4 out of 31 patients died. Tumours are positive for epithelial markers, and for S100 or GFAP, or myogenic markers (Gleason and Fletcher, 2007) .
Epidemiology
One case to date, a 40-year-old female patient. After surgical removal, recurrences occured during 2 years, and metastases appeared 3 years later. The patient finally died 9.5 years after initial diagnosis (Brandal et al., 2009 ).
Cytogenetics
Cytogenetics Morphological
The t(19;22)(q13;q12) was found within a complex karyotype. 
Genes involved and proteins
ZNF444
EWSR1
Location 22q12 Protein From N-term to C-term: a transactivation domain (TAD) containing multiple degenerate hexapeptide repeats, 3 arginine/glycine rich domains (RGG regions), a RNA recognition motif, and a RanBP2 type Zinc finger. Role in transcriptional regulation for specific genes and in mRNA splicing.
Result of the chromosomal anomaly
Hybrid Gene
Description 5' EWSR1 -3' ZNF444; fuses EWSR1 exon 8 to the very near end of ZNF444 (at nucleotide 967, while the full transcript of ZNF444 is 984 nt long!).
Fusion Protein
Description Truncated EWSR1 with 6 amino acids added from ZNF444. This does not fit with the usual model of carcinogenesis found with other EWSR1 translocations, were there is fusion of the N terminal transactivation domain of EWSR1 to the DNA binding domain of the partner (e.g. FLI1).
